X
Xin Wang
Researcher at Peking University
Publications - 1043
Citations - 30114
Xin Wang is an academic researcher from Peking University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 59, co-authored 762 publications receiving 22731 citations. Previous affiliations of Xin Wang include Beihang University & Sichuan University.
Papers
More filters
Journal ArticleDOI
S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial
Ye Chen,Jing Wu,Ke Cheng,Zhiping Li,Deyun Luo,Meng Qiu,Hongfeng Gou,Cheng Yi,Qiu Li,Xin Wang,Yu Yang,Dan Cao,Yali Shen,Feng Bi,Ji-Yan Liu +14 more
TL;DR: S‐1 combined with raltitrexed for refractory mCRC showed moderate effect, and it is worthy of further study as third‐ or later‐line therapy in mC RC.
Journal ArticleDOI
Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial
Wei Dai,Wenhong Peng,Yuan-Qiang Zhang,Xin Shelley Wang,Yangjun Liu,Cecilia Pompili,Weiwei Xu,Shaohua Xie,Yaqin Wang,Jia Liao,Xing Wei,Run Xiang,Bin-Hsiung Hu,Bo Tian,Xiaojun Yang,Xiang Wang,Ping Xiao,Q. Lai,Xin Wang,Bangrong Cao,Lifeng Wang,Fang Liu,Xiaoqin Liu,Tianpeng Xie,Xiang Zhuang,Guowei Che,Qiang Li,Qiuling Shi +27 more
TL;DR: Pro-based symptom management after lung cancer surgery showed lower symptom burden and fewer complications than usual care for up to 4 weeks postdischarge, and may be the preferred patient care approach following Lung cancer surgery.
Journal ArticleDOI
Examination of the Glycine Betaine-Dependent Methylotrophic Methanogenesis Pathway: Insights Into Anaerobic Quaternary Amine Methylotrophy.
TL;DR: Demonstration of the complete GB:CoM pathway expands the knowledge of direct QA-dependent methylotrophy and establishes a model to identify additional ecologically relevant anaerobic quaternary amine pathways.
Journal ArticleDOI
Enhanced anticancer performances of doxorubicin loaded macro-mesoporous silica nanoparticles with host-metal-guest structure
TL;DR: A novel carrier with pH-triggered release and high anti-cancer activity for DOX delivery system, which has great value in anticancer treatment is developed.
Journal ArticleDOI
Targeting HCCR expression resensitizes gastric cancer cells to chemotherapy via down-regulating the activation of STAT3.
Junling Zhang,Xiang-Zheng Liu,Pengyuan Wang,Guowei Chen,Yong Jiang,Shu-Kai Qiao,Jing Zhu,Xin Wang,Yisheng Pan,Yucun Liu +9 more
TL;DR: It is demonstrated that HCCR is probably involved in apoptosis and cancer growth and that it functions as a p-STAT3 stimulator in a positive feedback loop model and confers a more aggressive phenotype and resistance to 5-FU-based chemotherapy in gastric cancer cells.